| Name | Title | Contact Details |
|---|
Healthcare Management Television is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
A10 Clinical Solutions is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Emergency Care Programs is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Excelera is a national network of academic medical centers and integrated delivery networks with specialty pharmacy capabilities. Excelera supports its members by using sophisticated data management, reporting and analytical capabilities; secures access to limited distribution specialty pharmaceuticals; and provides clinical care protocols and best practices. Excelera is grounded in the simple premise that health systems, along with their specialist physicians, are best equipped to produce optimal health and financial outcomes for complex patients because they are the central hub for coordinating and integrating care needs, managing the electronic medical record, and providing a high-touch local service.
Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.